SNWV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SNWV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
SANUWAVE Health's average Accounts Payable for the three months ended in Sep. 2024 was $4.01 Mil. SANUWAVE Health's Cost of Goods Sold for the three months ended in Sep. 2024 was $2.29 Mil. Hence, SANUWAVE Health's Days Payable for the three months ended in Sep. 2024 was 159.74.
The historical rank and industry rank for SANUWAVE Health's Days Payable or its related term are showing as below:
During the past 13 years, SANUWAVE Health's highest Days Payable was 1666.63. The lowest was 214.82. And the median was 660.04.
SANUWAVE Health's Days Payable declined from Sep. 2023 (306.39) to Sep. 2024 (159.74). It may suggest that SANUWAVE Health accelerated paying its suppliers.
The historical data trend for SANUWAVE Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Payable | Get a 7-Day Free Trial | 1,026.60 | 925.54 | 442.82 | 507.51 | 305.58 |
SANUWAVE Health Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Days Payable | Get a 7-Day Free Trial | 306.39 | 218.26 | 310.13 | 212.53 | 159.74 |
For the Medical Devices subindustry, SANUWAVE Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Days Payable distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SANUWAVE Health's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as
Days Payable (A: Dec. 2023 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (A: Dec. 2022 ) | + | Accounts Payable (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (4.4 | + | 5.705) | / | 2 ) | / | 6.035 | * | 365 |
= | 5.0525 | / | 6.035 | * | 365 | ||||
= | 305.58 |
SANUWAVE Health's Days Payable for the quarter that ended in Sep. 2024 is calculated as:
Days Payable (Q: Sep. 2024 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (Q: Jun. 2024 ) | + | Accounts Payable (Q: Sep. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Sep. 2024 ) | * | Days in Period |
= | ( (3.891 | + | 4.137) | / | 2 ) | / | 2.293 | * | 365 / 4 |
= | 4.014 | / | 2.293 | * | 365 / 4 | ||||
= | 159.74 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of SANUWAVE Health's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Andrew Walko | officer: President | 11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344 |
Manchester Management Pr, Llc | director, other: Director by Deputization | 3 WEST HILL PLACE, BOSTON MA 02114 |
James E Besser | director, other: Director by Deputization | 3 WEST HILL PLACE, BOSTON MA 02114 |
Manchester Explorer, L.p. | director, other: Director by Deputization | MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114 |
Morgan C. Frank | director | 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907 |
Manchester Management Co Llc | director, other: Director by Deputization | 3 WEST HILL PLACE, BOSTON MA 02110 |
Thomas Edmunds Price | director | 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024 |
Shri P. Parikh | officer: President | 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024 |
Richardson Kevin A Ii | 10 percent owner | 200 HIGH STREET, SUITE 700, BOSTON MA 02110 |
Anthony Michael Stolarski | director | 99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841 |
Sanuwave Health, Inc. | director | 3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024 |
Lisa E Sundstrom | officer: Interim CFO | 11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022 |
Joseph Chiarelli | director, officer: Chief Executive Officer | 510 FAIRVIEW AVENUE, WYCKOFF NJ 07481 |
Barry J. Jenkins | officer: Chief Financial Officer | 11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022 |
Alan L Rubino | director | PO BOX 376, LOBBY L., ANN ARBOR MI 48105 |
From GuruFocus
By Marketwired • 08-11-2023
By GuruFocus Research • 02-15-2024
By GuruFocus Research • 02-15-2024
By GuruFocus Research • 05-13-2024
By GuruFocus News • 11-08-2024
By GuruFocus Research • 05-13-2024
By GuruFocus Research • 03-23-2024
By GuruFocus Research • 02-15-2024
By GuruFocus Research • 02-15-2024
By Marketwired • 08-13-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.